Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China 7
This section reviews key ligands, including RGD peptide, chlorotoxin, Angiopep-2, interleukin-13 (IL-13), epidermal growth factor receptor (EGFR/EGFRvIII), and aptamer AS1411, highlighting their mechanisms and potential in MSN-based GBM therapy
You'll be notified when your order is dispatched
Retatrutide Peptide Research Retatrutide has gained increasing attention in scientific research due to its interaction with multiple receptor pathways involved in metabolic signaling
This fragmented approach limits the sustainability of therapeutic effects, particularly in hypothyroid patients with profound metabolic and inflammatory dysregulation
The study followed a target trial emulation design that used data from electronic health records (EHR) from 2014 to 2024 and investigated incidence of 14 cancer types, including 13 obesity-associated cancers (liver, thyroid, pancreatic, bladder, colorectal, kidney, breast, endometrial, meningioma, upper gastrointestinal, ovarian, multiple myeloma, prostate) and lung cancer
